Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon
- PMID: 27222717
- PMCID: PMC4872368
- DOI: 10.1016/j.nmni.2016.04.005
Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon
Abstract
Acinetobacter spp. have emerged as global opportunistic pathogen causing a wide range of infections. Emergence of carbapenem resistance in these organisms is a matter of great concern. We report here the first detection of Acinetobacter pittii clinical isolates in Lebanon carrying either the bla NDM-1 or the bla OXA-72 gene.
Keywords: Acinetobacter pittii; Lebanon; blaNDM-1; blaOxa-72; carbapenem resistance.
Similar articles
-
Detection of co-harboring OXA-58 and NDM-1 carbapenemase producing genes resided on a same plasmid from an Acinetobacter pittii clinical isolate in China.Iran J Basic Med Sci. 2019 Jan;22(1):106-111. doi: 10.22038/ijbms.2018.28934.6994. Iran J Basic Med Sci. 2019. PMID: 30944716 Free PMC article.
-
Phenotypic Variation and Carbapenem Resistance Potential in OXA-499-Producing Acinetobacter pittii.Front Microbiol. 2020 Jun 9;11:1134. doi: 10.3389/fmicb.2020.01134. eCollection 2020. Front Microbiol. 2020. PMID: 32582088 Free PMC article.
-
Detection of Acinetobacter pittii ST220 co-producing NDM-1 and OXA-820 carbapenemases from a hospital sink in a non-endemic country of NDM.J Glob Antimicrob Resist. 2020 Jun;21:353-356. doi: 10.1016/j.jgar.2019.11.013. Epub 2019 Nov 27. J Glob Antimicrob Resist. 2020. PMID: 31783194
-
Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014.Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02007-18. doi: 10.1128/AAC.02007-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670429 Free PMC article.
-
Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.J Med Microbiol. 2018 Dec;67(12):1667-1672. doi: 10.1099/jmm.0.000845. Epub 2018 Oct 12. J Med Microbiol. 2018. PMID: 30311872
Cited by
-
Carbapenemase genes in clinical and environmental isolates of Acinetobacter spp. from Quito, Ecuador.PeerJ. 2024 Apr 25;12:e17199. doi: 10.7717/peerj.17199. eCollection 2024. PeerJ. 2024. PMID: 38680892 Free PMC article.
-
Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon.BMC Microbiol. 2019 Feb 2;19(1):29. doi: 10.1186/s12866-019-1401-2. BMC Microbiol. 2019. PMID: 30710998 Free PMC article.
-
Acinetobacter pittii from Companion Animals Coharboring blaOXA-58, the tet(39) Region, and Other Resistance Genes on a Single Plasmid.Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01993-17. doi: 10.1128/AAC.01993-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29109166 Free PMC article. No abstract available.
-
Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.Front Microbiol. 2019 Aug 23;10:1941. doi: 10.3389/fmicb.2019.01941. eCollection 2019. Front Microbiol. 2019. PMID: 31507558 Free PMC article. Review.
References
-
- Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39:105–114. - PubMed
-
- Zhang R., Hu Y.Y., Yang X.F., Gu D.X., Zhou H.W., Hu Q.F. Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China. Eur J Clin Microbiol Infect Dis. 2014;33:853–860. - PubMed
-
- Gundi V.A., Dijkshoorn L., Burignat S., Raoult D., La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009;155:2333–2341. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous